List of works - Francis Jay Mussai

Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment

scientific article published on 3 June 2013

Adjunctive Treatment in Juvenile Nasopharyngeal Angiofibroma: How Should We Approach Recurrence?

scientific article published on 22 February 2016

Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies

scientific article published on 29 June 2017

Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.

scientific article published on 20 February 2015

Challenges of clinical trial design for targeted agents against pediatric leukemias

scientific article

Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

scientific article published on 17 January 2019

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia

scientific article published on 07 June 2010

Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737.

scientific article published on June 2011

Enteroviral Encephalitis in a Child With CNS Relapse of Burkitt Leukemia Treated With Rituximab.

scientific article published on 8 January 2018

Hemophagocytic Lymphohistiocytosis Associated With 2 Cases of Pediatric Lymphocyte-depleted Classic Hodgkin Lymphoma

scientific article published on 01 July 2019

Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunities

scientific article published on July 2012

MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers

scientific article published on 25 August 2019

Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma

scientific article published on 13 December 2018

Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma.

scientific article published on 18 May 2018

Molecular basis and current strategies of therapeutic arginine depletion for cancer.

scientific article published on 23 February 2016

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

scientific article published on 8 June 2015

Neuroblastoma arginine addiction subverts the anticancer immune response.

scientific article published on 11 November 2015

TB-12ARGININE AUXOTROPHY IN PAEDIATRIC CNS TUMOURS: THE RATIONALE FOR THERAPEUTIC ARGININE DEPLETION AS A NOVEL ANTI-CANCER THERAPY.